Suspension of trading

Income Statement SurModics

Stocks

SRDX

US8688731004

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 02:30:00 19/11/2025 am IST			5-day change	1st Jan Change
42.98 ^USD	+0.35%		-.--%	-

19/05	Endologix LLC acquired Pounce? Thrombectomy System from Surmodics, Inc.	CI
10/12	Surmodics, Inc. acquired certain assets from Biocoat, Incorporated.	CI

e65e.w1vBzVEzk8ynFOr7Ziar2k9aZhgkLaF2IdyGCkFY21w.9h2F-Tt024vkJ7u3L23yqCUOBVMcYflBUoPOYA0MjCm0DoP8F17Wo8wivw

Published financial data: SURMODICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020	2021	2022	2023	2024
Revenues	9.49Cr	11Cr	10Cr	13Cr	13Cr
Total Revenues	9.49Cr	11Cr	10Cr	13Cr	13Cr
Cost of Goods Sold, Total	6.55Cr	6.66Cr	7.1Cr	2.5Cr	3.3Cr
Gross Profit	2.94Cr	3.85Cr	2.9Cr	11Cr	9.31Cr
Selling General & Admin Expenses, Total	2.84Cr	3.16Cr	4.69Cr	5.19Cr	5.31Cr
R&D Expenses	-	-	-	4.66Cr	3.84Cr
Amortization of Goodwill and Intangible Assets - (IS)	22.18L	27.93L	41.5L	35.37L	35.01L
Other Operating Expenses, Total	3.06Cr	3.44Cr	5.11Cr	10Cr	9.5Cr
Operating Income	-12.51L	41.55L	-2.21Cr	56.03L	-19.45L
Interest Expense, Total	-1L	-3L	-6L	-34.89L	-35.4L
Interest And Investment Income	7L	1L	99T	10.77L	19.22L
Net Interest Expenses	5L	-2L	-5L	-24.12L	-16.18L
Currency Exchange Gains (Loss)	-2L	-2L	1L	-3L	-2L
Other Non Operating Income (Expenses)	1T	-	-	-	-
EBT, Excl. Unusual Items	-10L	37.98L	-2.25Cr	29.4L	-38.06L
Restructuring Charges	-	-	-	-12.82L	-
Merger & Related Restructuring Charges	-	-10.49L	-	-	-37L
Gain (Loss) On Sale Of Investments	-5L	-	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	35.97L	-12T	8L	-
EBT, Incl. Unusual Items	-14.54L	63.46L	-2.25Cr	24.87L	-75.06L
Income Tax Expense	-25.77L	21.09L	47.81L	40.23L	40.36L
Earnings From Continuing Operations	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Net Income to Company	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Net Income - (IS)	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Net Income to Common Incl Extra Items	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Net Income to Common Excl. Extra Items	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Per Share Items
Net EPS - Basic	0.08	0.31	-1.96	-0.11	-0.82
Basic EPS - Continuing Operations	0.08	0.31	-1.96	-0.11	-0.82
Basic Weighted Average Shares Outstanding	1.36Cr	1.38Cr	1.39Cr	1.4Cr	1.42Cr
Net EPS - Diluted	0.08	0.3	-1.96	-0.11	-0.82
Diluted EPS - Continuing Operations	0.08	0.3	-1.96	-0.11	-0.82
Diluted Weighted Average Shares Outstanding	1.38Cr	1.4Cr	1.39Cr	1.4Cr	1.42Cr
Normalized Basic EPS	-0.04	0.17	-1.01	0.13	-0.17
Normalized Diluted EPS	-0.04	0.17	-1.01	0.13	-0.17
Supplemental Items
EBITDA	60.12L	1.22Cr	-1.29Cr	1.41Cr	67.49L
EBITA	12.49L	72.55L	-1.77Cr	94.03L	18.55L
EBIT	-12.51L	41.55L	-2.21Cr	56.03L	-19.45L
EBITDAR	66.12L	1.3Cr	-1.18Cr	1.55Cr	83.49L
Total Revenues (As Reported)	9.49Cr	11Cr	10Cr	13Cr	13Cr
Effective Tax Rate - (Ratio)	177.24	33.23	-21.26	161.76	-53.77
Current Domestic Taxes	-15.28L	4L	-7L	39.54L	41.41L
Current Foreign Taxes	90T	87T	2L	2L	2L
Total Current Taxes	-14.38L	5L	-5L	42.04L	43.56L
Deferred Domestic Taxes	-11.39L	17.89L	57.15L	-	-
Deferred Foreign Taxes	-	-1L	-4L	-2L	-3L
Total Deferred Taxes	-11.39L	16.51L	52.68L	-2L	-3L
Normalized Net Income	-6L	23.74L	-1.41Cr	18.38L	-23.79L
Interest on Long-Term Debt	1L	-	6L	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	5.02Cr	4.67Cr	5.06Cr	4.66Cr	3.84Cr
Net Rental Expense, Total	6L	8L	11L	14L	16L
Imputed Operating Lease Interest Expense	-	2L	4L	16.26L	13.63L
Imputed Operating Lease Depreciation	-	6L	7L	-2L	2L
Stock-Based Comp., COGS (Total)	10.15L	14.2L	16.58L	3L	3L
Stock-Based Comp., R&D Exp. (Total)	-	-	-	14.17L	15.17L
Stock-Based Comp., SG&A Exp. (Total)	44.38L	44.43L	53.99L	59.09L	64.18L
Total Stock-Based Compensation	54.53L	58.63L	70.57L	76.05L	82.17L

Fiscal Period: September	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.08Cr	3.12Cr	1.9Cr	4.14Cr	3.61Cr
Short Term Investments	3.03Cr	77.17L	-	39.33L	39.97L
Total Cash And Short Term Investments	6.11Cr	3.89Cr	1.9Cr	4.54Cr	4.01Cr
Accounts Receivable, Total	1.38Cr	1.63Cr	1.76Cr	1.86Cr	2.32Cr
Other Receivables	23.91L	66.53L	66.32L	52.54L	1L
Total Receivables	1.62Cr	2.29Cr	2.42Cr	2.39Cr	2.33Cr
Inventory	59.66L	67.6L	1.18Cr	1.48Cr	1.52Cr
Prepaid Expenses	33.7L	17.12L	25.7L	26L	27.52L
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Total Current Assets	8.66Cr	7.03Cr	5.76Cr	8.67Cr	8.13Cr
Gross Property Plant And Equipment	7.56Cr	8.02Cr	8.21Cr	8.55Cr	8.98Cr
Accumulated Depreciation	-4.3Cr	-4.77Cr	-5.13Cr	-5.65Cr	-6.18Cr
Net Property Plant And Equipment	3.26Cr	3.25Cr	3.08Cr	2.9Cr	2.8Cr
Long-term Investments	-	20.02L	-	-	-
Goodwill	2.72Cr	4.56Cr	4.07Cr	4.29Cr	4.46Cr
Other Intangibles, Total	1.33Cr	3.71Cr	2.81Cr	2.62Cr	2.36Cr
Accounts Receivable Long-Term	-	-	-	-	7L
Deferred Tax Assets Long-Term	73.15L	58.67L	-	-	-
Other Long-Term Assets, Total	17.61L	12.83L	11.36L	9L	4L
Total Assets	17Cr	19Cr	16Cr	19Cr	18Cr
Liabilities
Accounts Payable, Total	15.15L	17.83L	31.36L	29.93L	27.86L
Accrued Expenses, Total	1Cr	1.22Cr	1.28Cr	1.3Cr	1.39Cr
Short-term Borrowings	-	1Cr	1Cr	-	-
Current Portion of Leases	4L	5L	10L	9L	10.4L
Current Income Taxes Payable	-	-	-	-	12.44L
Unearned Revenue Current, Total	52L	46.47L	41.6L	43.78L	16.19L
Other Current Liabilities	17.41L	6L	10L	26.61L	-
Total Current Liabilities	1.89Cr	2.98Cr	3.21Cr	2.4Cr	2.05Cr
Long-Term Debt	-	-	-	2.94Cr	2.96Cr
Long-Term Leases	33.4L	31.88L	38.43L	29.74L	26.48L
Unearned Revenue Non Current	1.08Cr	1.03Cr	50.88L	24L	-
Deferred Tax Liability Non Current	-	27.42L	20.27L	20.04L	17.85L
Other Non Current Liabilities	46.8L	84.61L	69.3L	50.86L	51.35L
Total Liabilities	3.77Cr	5.45Cr	5Cr	6.58Cr	5.97Cr
Common Stock, Total	7L	7L	7L	7L	7L
Additional Paid In Capital	1.54Cr	2.16Cr	2.88Cr	3.67Cr	4.46Cr
Retained Earnings	11Cr	12Cr	8.88Cr	8.73Cr	7.57Cr
Comprehensive Income and Other	31.74L	17.27L	-98.74L	-47.59L	-21.26L
Total Common Equity	13Cr	14Cr	11Cr	12Cr	12Cr
Total Equity	13Cr	14Cr	11Cr	12Cr	12Cr
Total Liabilities And Equity	17Cr	19Cr	16Cr	19Cr	18Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.37Cr	1.39Cr	1.4Cr	1.42Cr	1.43Cr
ECS Total Common Shares Outstanding	1.37Cr	1.39Cr	1.4Cr	1.42Cr	1.43Cr
Book Value / Share	9.59	10.08	7.73	8.47	8.3
Tangible Book Value	9.06Cr	5.74Cr	3.95Cr	5.08Cr	5.07Cr
Tangible Book Value Per Share	6.63	4.13	2.82	3.59	3.54
Total Debt	37.76L	1.37Cr	1.48Cr	3.33Cr	3.32Cr
Net Debt	-5.73Cr	-2.52Cr	-41.92L	-1.21Cr	-68.7L
Debt Equivalent Oper. Leases	48L	64L	88L	1.12Cr	1.28Cr
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Raw Materials, Total	37.58L	41.65L	61.02L	80.63L	85.05L
Inventories - Work In Process, Total	8L	12.95L	15.95L	26.07L	24.76L
Inventories - Finished Goods, Total	13.91L	13L	41.22L	41.69L	41.87L
Land - (BS)	44.19L	44.19L	44.09L	44.13L	44.16L
Buildings, Total	2.56Cr	2.66Cr	2.64Cr	2.7Cr	2.95Cr
Machinery, Total	3.59Cr	3.82Cr	3.8Cr	4.27Cr	4.49Cr
Full Time Employees	370	389	447	376	389
Accumulated Allowance for Doubtful Accounts (Supple)	1L	1L	81T	80T	1L

Fiscal Period: September	2020	2021	2022	2023	2024
Net Income	11.23L	42.37L	-2.73Cr	-15.36L	-1.15Cr
Depreciation & Amortization - CF	47.63L	49.17L	47.42L	47.22L	48.94L
Amortization of Goodwill and Intangible Assets - (CF)	25L	31L	44L	38L	38L
Depreciation & Amortization, Total	72.63L	80.17L	91.42L	85.22L	86.94L
Amortization of Deferred Charges, Total - (CF)	-	-	-	4L	3L
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	5L	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	54.53L	58.63L	70.57L	76.05L	82.17L
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	73T	-11T	5T	37T	64T
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-14.96L	21.4L	61.23L	-2L	-1L
Change In Accounts Receivable	34.61L	-24.8L	-15.22L	-10L	-52.36L
Change In Inventories	-13.77L	-8L	-50.6L	-30.2L	-3L
Change In Accounts Payable	-5L	3L	16.08L	-2L	-2L
Change in Unearned Revenues	-11.85L	-10.48L	-57L	-24.7L	-51.59L
Change In Income Taxes	-15.58L	2L	-10.69L	34.38L	15.79L
Change in Other Net Operating Assets	22.57L	-10L	-5L	-10.24L	40.17L
Cash from Operations	1.4Cr	1.54Cr	-1.72Cr	1.05Cr	2L
Capital Expenditure	-36.71L	-52.79L	-33.7L	-29.18L	-34.92L
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-3.96Cr	-	-	-
Sale (Purchase) of Intangible assets	-	-10L	-	-	-
Investment in Marketable and Equity Securities, Total	-53.95L	2.06Cr	96L	-39.04L	6L
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-90.66L	-2.52Cr	62.3L	-68.22L	-29.37L
Short Term Debt Issued, Total	-	1Cr	-	-	-
Long-Term Debt Issued, Total	-	-	-	2.97Cr	-
Total Debt Issued	-	1Cr	-	2.97Cr	-
Short Term Debt Repaid, Total	-	-	-	-1Cr	-
Total Debt Repaid	-	-	-	-1Cr	-
Issuance of Common Stock	16.15L	31.28L	12.46L	12.52L	12.16L
Repurchase of Common Stock	-25.34L	-27.51L	-11.21L	-9L	-15.37L
Other Financing Activities, Total	-37.29L	-2L	-5L	-15.92L	-26.29L
Cash from Financing	-46.48L	1.02Cr	-4L	1.84Cr	-29.5L
Foreign Exchange Rate Adjustments	1L	-10T	-8L	3L	3L
Net Change in Cash	4L	4L	-1.22Cr	2.24Cr	-53.04L
Supplemental Items
Cash Interest Paid	-	74T	4L	29.19L	30.45L
Cash Income Tax Paid (Refund)	30T	2L	4L	28.51L	25.68L
Levered Free Cash Flow	70.45L	49.7L	-67.33L	1.41Cr	68.62L
Unlevered Free Cash Flow	71.28L	51.64L	-63.59L	1.59Cr	87.71L
Change In Net Working Capital	11.35L	50.34L	53.85L	8L	34.32L
Net Debt Issued / Repaid	-	1Cr	-	1.97Cr	-

Fiscal Period: September	2020	2021	2022	2023	2024
Profitability
Return on Assets	-0.48	1.43	-7.82	2.04	-0.67
Return on Total Capital	-0.61	1.8	-9.97	2.53	-0.8
Return On Equity %	0.89	3.13	-21.95	-1.35	-9.67
Return on Common Equity	0.89	3.13	-21.95	-1.35	-9.67
Margin Analysis
Gross Profit Margin %	30.95	36.64	29.01	81.17	73.81
SG&A Margin	29.93	30.03	46.96	39.13	42.15
EBITDA Margin %	6.34	11.58	-12.95	10.65	5.35
EBITA Margin %	1.32	6.9	-17.69	7.09	1.47
EBIT Margin %	-1.32	3.95	-22.1	4.23	-1.54
Income From Continuing Operations Margin %	1.18	4.03	-27.29	-1.16	-9.15
Net Income Margin %	1.18	4.03	-27.29	-1.16	-9.15
Net Avail. For Common Margin %	1.18	4.03	-27.29	-1.16	-9.15
Normalized Net Income Margin	-0.64	2.26	-14.06	1.39	-1.89
Levered Free Cash Flow Margin	7.43	4.73	-6.74	10.64	5.44
Unlevered Free Cash Flow Margin	7.51	4.91	-6.36	12.01	6.96
Asset Turnover
Asset Turnover	0.58	0.58	0.57	0.77	0.69
Fixed Assets Turnover	3.04	3.23	3.16	4.43	4.42
Receivables Turnover (Average Receivables)	6.12	7	5.91	7.32	6.03
Inventory Turnover (Average Inventory)	12.52	10.47	7.64	1.87	2.2
Short Term Liquidity
Current Ratio	4.58	2.36	1.8	3.62	3.96
Quick Ratio	4.09	2.07	1.35	2.89	3.09
Operating Cash Flow to Current Liabilities	0.74	0.52	-0.54	0.44	0.01
Days Sales Outstanding (Average Receivables)	59.77	52.15	61.77	49.85	60.69
Days Outstanding Inventory (Average Inventory)	29.24	34.87	47.79	194.88	166.27
Average Days Payable Outstanding	9.84	8.93	11.81	39.97	31.71
Cash Conversion Cycle (Average Days)	79.18	78.09	97.74	204.75	195.25
Long Term Solvency
Total Debt/Equity	2.88	9.78	13.66	27.73	27.96
Total Debt / Total Capital	2.8	8.91	12.02	21.71	21.85
LT Debt/Equity	2.55	2.28	3.55	27	27.08
Long-Term Debt / Total Capital	2.48	2.07	3.12	21.14	21.17
Total Liabilities / Total Assets	22.34	28.01	31.55	35.44	33.41
EBIT / Interest Expense	-9.41	13.4	-36.93	1.61	-0.55
EBITDA / Interest Expense	49.71	41.85	-19.8	4.45	2.36
(EBITDA - Capex) / Interest Expense	22.11	24.82	-25.44	3.61	1.37
Total Debt / EBITDA	0.57	1.06	-1.25	2.14	3.98
Net Debt / EBITDA	-8.67	-1.94	0.35	-0.78	-0.82
Total Debt / (EBITDA - Capex)	1.28	1.78	-0.97	2.64	6.84
Net Debt / (EBITDA - Capex)	-19.49	-3.27	0.28	-0.96	-1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.21	10.83	-4.93	32.65	-4.91
Gross Profit, 1 Yr. Growth %	-13.17	31.22	-24.72	35.18	-13.54
EBITDA, 1 Yr. Growth %	-57.57	102.46	-206.33	-209.13	-52.22
EBITA, 1 Yr. Growth %	-86.79	480.86	-343.76	-153.17	-80.27
EBIT, 1 Yr. Growth %	-118.24	-432.13	-631.53	-125.37	-134.71
Earnings From Cont. Operations, 1 Yr. Growth %	-85.21	277.29	-743.71	-94.37	651.43
Net Income, 1 Yr. Growth %	-85.21	277.29	-743.71	-94.37	651.43
Normalized Net Income, 1 Yr. Growth %	-112.28	-489.54	-691.92	-113.08	-229.46
Diluted EPS Before Extra, 1 Yr. Growth %	-85.45	275	-753.33	-94.39	645.45
Accounts Receivable, 1 Yr. Growth %	-19.88	17.97	8.04	6.14	24.23
Inventory, 1 Yr. Growth %	32.55	13.31	74.84	25.55	2.22
Net Property, Plant and Equip., 1 Yr. Growth %	9.62	-0.26	-5.36	-5.74	-3.55
Total Assets, 1 Yr. Growth %	5.57	15.3	-18.62	17.29	-3.86
Tangible Book Value, 1 Yr. Growth %	10.31	-36.61	-31.15	28.38	-0.14
Common Equity, 1 Yr. Growth %	6.97	6.89	-22.62	10.63	-0.84
Cash From Operations, 1 Yr. Growth %	74.3	9.84	-211.92	-161.05	-97.64
Capital Expenditures, 1 Yr. Growth %	-38.8	43.8	-36.16	-13.41	19.67
Levered Free Cash Flow, 1 Yr. Growth %	-149.05	-29.45	-235.47	-311.03	-51.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-149.96	-27.56	-223.15	-350.46	-44.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8	2.5	2.65	12.3	12.31
Gross Profit, 2 Yr. CAGR %	5.52	6.74	-0.61	10.93	8.11
EBITDA, 2 Yr. CAGR %	-8.59	-7.31	46.73	7.72	-27.79
EBITA, 2 Yr. CAGR %	-39.95	-12.41	276.29	13.85	-67.61
EBIT, 2 Yr. CAGR %	27.96	-22.16	320.17	16.12	-70.32
Earnings From Cont. Operations, 2 Yr. CAGR %	-49.8	-25.29	392.82	-39.79	-34.95
Net Income, 2 Yr. CAGR %	-49.8	-25.29	392.82	-39.79	-34.95
Normalized Net Income, 2 Yr. CAGR %	-27.48	-30.83	380.18	-12.02	-58.85
Diluted EPS Before Extra, 2 Yr. CAGR %	-51.49	-26.15	394.97	-39.45	-35.32
Accounts Receivable, 2 Yr. CAGR %	24.61	-2.78	12.9	7.09	14.83
Inventory, 2 Yr. CAGR %	21.88	22.55	40.75	48.16	13.29
Net Property, Plant and Equip., 2 Yr. CAGR %	4.01	4.56	-2.85	-5.55	-4.65
Total Assets, 2 Yr. CAGR %	1.4	10.33	-3.13	-2.3	6.19
Tangible Book Value, 2 Yr. CAGR %	19.07	-16.38	-33.94	-5.98	13.23
Common Equity, 2 Yr. CAGR %	9.85	6.93	-9.06	-7.48	4.73
Cash From Operations, 2 Yr. CAGR %	-35.86	38.37	10.88	-17.34	-88
Capital Expenditures, 2 Yr. CAGR %	-36.46	-6.18	-4.19	-25.65	1.79
Levered Free Cash Flow, 2 Yr. CAGR %	-38.53	-41.18	-2.24	67.73	1.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-38.17	-39.84	-5.55	75.62	17.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.07	8.93	-0.04	11.81	6.24
Gross Profit, 3 Yr. CAGR %	-0.91	13.47	-4.99	54.19	2.09
EBITDA, 3 Yr. CAGR %	-22.53	19.15	-2.97	32.94	-17.85
EBITA, 3 Yr. CAGR %	-49.67	27.94	23.2	95.99	-36.53
EBIT, 3 Yr. CAGR %	-44.65	75.86	47.68	64.84	-22.35
Earnings From Cont. Operations, 3 Yr. CAGR %	-34.11	-1.67	53.15	11	39.66
Net Income, 3 Yr. CAGR %	-34.11	-1.67	53.15	11	39.66
Normalized Net Income, 3 Yr. CAGR %	-48.8	27	41.48	44.47	0.07
Diluted EPS Before Extra, 3 Yr. CAGR %	-34.9	-4.09	52.74	11.2	39.82
Accounts Receivable, 3 Yr. CAGR %	24.1	22.35	0.7	10.6	12.52
Inventory, 3 Yr. CAGR %	19.27	18.96	37.96	35.49	30.92
Net Property, Plant and Equip., 3 Yr. CAGR %	12.44	2.57	1.14	-3.82	-4.89
Total Assets, 3 Yr. CAGR %	7.3	5.84	-0.32	3.25	-2.82
Tangible Book Value, 3 Yr. CAGR %	12.45	-3.5	-21.62	-17.56	-4.07
Common Equity, 3 Yr. CAGR %	5.52	8.85	-4	-2.92	-5.32
Cash From Operations, 3 Yr. CAGR %	-0.1	-23.26	28.92	-9.13	-74.74
Capital Expenditures, 3 Yr. CAGR %	-17.05	-16.57	-17.48	-7.37	-12.87
Levered Free Cash Flow, 3 Yr. CAGR %	5.83	-35.64	-22.32	26.06	11.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.25	-34.81	-23.62	30.73	19.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.91	8.06	6.45	10.27	4.73
Gross Profit, 5 Yr. CAGR %	-4.58	-1.69	-0.79	32.49	22.44
EBITDA, 5 Yr. CAGR %	-25.61	-14.35	0.02	14.44	-13.79
EBITA, 5 Yr. CAGR %	-44.73	-21.24	12.54	22.11	-27.8
EBIT, 5 Yr. CAGR %	-44.42	-28.04	24.52	48.96	-22.28
Earnings From Cont. Operations, 5 Yr. CAGR %	-37.68	-15.76	47.35	-19.19	8.74
Net Income, 5 Yr. CAGR %	-37.68	-15.76	47.35	-19.19	8.74
Normalized Net Income, 5 Yr. CAGR %	-47.2	-29.04	25.35	9.66	-13.67
Diluted EPS Before Extra, 5 Yr. CAGR %	-38.37	-16.96	46.55	-20.2	8.32
Accounts Receivable, 5 Yr. CAGR %	13.01	18.81	19.49	16	6.13
Inventory, 5 Yr. CAGR %	14.9	13.56	27.44	29.87	27.5
Net Property, Plant and Equip., 5 Yr. CAGR %	20.25	10.66	6.05	-0.76	-1.22
Total Assets, 5 Yr. CAGR %	11.32	7.93	3	2.5	2.24
Tangible Book Value, 5 Yr. CAGR %	2.24	-0.11	-9.1	-4.5	-9.2
Common Equity, 5 Yr. CAGR %	7.36	5.57	-0.57	2	-0.6
Cash From Operations, 5 Yr. CAGR %	-1.38	-9.37	4.15	-20.95	-50.13
Capital Expenditures, 5 Yr. CAGR %	14.36	-8.41	-12.13	-20.33	-10.25
Levered Free Cash Flow, 5 Yr. CAGR %	-14.27	-24.31	2.53	-5.42	-13.73
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.07	-23.73	1.36	-3.1	-9.27